Vincent Lo Re, III, FISPE – the University of Pennsylvania ### 1074389###Moderator###Associate Professor of Medicine and Epidemiology###the University of Pennsylvania###
Moderator: Vincent Lo Re, III, FISPE – the University of Pennsylvania
@@@ Xin Sun – West China Hospital, Sichuan University ### 1074390###Speaker###Director###West China Hospital, Sichuan University###
Speaker: Xin Sun – West China Hospital, Sichuan University
@@@ Peter Arlett – European Medicines Agency ### 1074391###Speaker######European Medicines Agency###
Speaker: Peter Arlett – European Medicines Agency
@@@ Amy Abernethy, MD, PhD – US Food and Drug Administration ### 1074392###Speaker###Principal Deputy Commissioner of Food and Drugs###US Food and Drug Administration###
Speaker: Amy Abernethy, MD, PhD – US Food and Drug Administration
Almut G. Winterstein, PhD,FISPE – University of Florida ### 1061393###Moderator######University of Florida###
Moderator: Almut G. Winterstein, PhD,FISPE – University of Florida
@@@ Shannon Sperati – International Society for Pharmacoepidemiology ### 1089040###ARS Moderator######International Society for Pharmacoepidemiology###
ARS Moderator: Shannon Sperati – International Society for Pharmacoepidemiology
Priya Bahri – European Medicines Agency ### 1061402###Moderator###Dr.###European Medicines Agency###
Moderator: Priya Bahri – European Medicines Agency
@@@ Elaine H. Morrato, MPH, DrPH – Loyola University Chicago ### 1046822###Speaker###Professor and Founding Dean###Loyola University Chicago###
Speaker: Elaine H. Morrato, MPH, DrPH – Loyola University Chicago
@@@ Hubert G. Leufkens, PhD, FISPE – University of Utrecht ### 1061394###Speaker######University of Utrecht###
Speaker: Hubert G. Leufkens, PhD, FISPE – University of Utrecht
@@@ François Houÿez – European Organisation for Rare Diseases ### 1061403###Speaker###Director of Treatment Information and Access###European Organisation for Rare Diseases###
Speaker: François Houÿez – European Organisation for Rare Diseases
@@@ Odette Wegwarth – Max Planck Institute for Human Development ### 1061404###Speaker######Max Planck Institute for Human Development###
Speaker: Odette Wegwarth – Max Planck Institute for Human Development
@@@ Sara J. ElShafie – University of California, Berkeley ### 1086451###Speaker###Doctoral Candidate###University of California, Berkeley###
Speaker: Sara J. ElShafie – University of California, Berkeley
Tobias Gerhard, PhD,FISPE – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1046831###Speaker######Rutgers Center for Pharmacoepidemiology and Treatment Science###
Speaker: Tobias Gerhard, PhD,FISPE – Rutgers Center for Pharmacoepidemiology and Treatment Science
